Krzys Misiukiewicz
Papers
2
Total Citations
21
H-Index
2
About
Krzysztof "Krzys" Misiukiewicz is a leading oncologist and translational researcher whose work focuses on the intersection of immunotherapy and head and neck cancers, particularly human papillomavirus-associated oropharyngeal cancer (HPVOPC). His major contributions center on pioneering the use of live attenuated *Listeria monocytogenes*-based immunotherapy (ADXS11-001) to target HPV E7 antigens. In a landmark "window of opportunity" trial, Misiukiewicz demonstrated that administering this immunotherapy prior to robotic surgery in HPV-positive oropharyngeal cancer patients could enhance HPV-specific T cell immunity within the tumor microenvironment. His 2016 study, which has garnered 19 citations, provided critical early evidence that this approach is both feasible and immunologically active, paving the way for neoadjuvant immunotherapy strategies. By showing measurable changes in local and peripheral T cell diversity, his work has helped establish a foundation for leveraging viral antigens to turn immunologically "cold" tumors hot. Misiukiewicz’s research is instrumental in shifting treatment paradigms toward less toxic, immune-driven therapies for HPV-driven malignancies, offering new hope for patients with this rapidly rising cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2